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Editors’ NotesIn from the Outside
Stem cell fates are influenced by external signals, such as thosemediated by growth factors, and the subsequent intracellular
transduction of those signals leads to epigenetic and genetic modifications that carry out the signaled change. Thomson and
colleagues add details to this paradigm in the context of influencing lineage choice during human ESC differentiation. The
authors show that NANOG expression can be maintained by FGF2-induced MEK-ERK signaling and, in doing so, can shift
the outcome of BMP4 exposure away from extraembryonic differentiation and toward a mesendoderm fate. In their
Minireview, Puri and colleagues tackle the question of how the intermediate steps between extrinsic signal cascades and
gene expression changes are mediated. They overview recent evidence that the PcG component EZH2 is a phosphoryla-
tion-regulated enzyme and discuss some speculative models as to how the implications of these findings will influence how
the field looks at modulating cell fate. Fuchs and coauthors, meanwhile, examine the issue of cell-fate
regulation in the skin and approach the question from an intracellular signaling perspective. They
show that miR-125b regulates lineage fate in hair follicle stem cells, engineer in vivo models to demon-
strate that this ‘‘stemness’’ associated microRNA tips the balance away from differentiation of lineage-
committed progeny, and identify specific targets that participate in the observed tissue imbalance.
Tools to Make Tools
Pluripotent stem cells offer a model to study early human development. However, primate and rodent
PSCs exhibit divergent traits, which limits the extent to which conclusions from mouse ESCs can be
extrapolated to studies of human embryology. In this issue, Tesar and colleagues extend their previous
work on epiblast stem cells (EpiSCs), which have been viewed as amore faithful rodentmodel of existing
human pluripotent cell lines. In their current article, the authors describe conditions that allow for the efficient derivation of
EpiSCs from various mouse strains. As Kunath discusses in his Preview article, in doing so, Najm et al. provide an important
tool that may allow researchers to glean more relevant developmental insight from studies of murine embryos. Kim and
colleagues look beyond the derivation of human ESCs and provide details of a method used to monitor their differentiation
into endodermal lineages and also to trace the fates of their differentiated progeny. By following the eGFP-marked
SOX17+ cell derivatives, the authors also identified cell surface markers that were used to isolate endodermal precursors
from unmodified hESC and hiPSC lines. Thus, in both cases, the authors offer important resources that will enrich the
experimental value of existing pluripotent lines and of the data that are generated from them.
Collaborating for the Future
The stem cell community lost one of its founders last month with the passing of Ernest McCulloch on January 20, 2011. In an
Obituary written in his honor, Norman Iscove provides us with an overview of some of McCulloch’s lasting contributions to
our field, including a survey of several of his original publications that came out of the lasting and fruitful collaboration with
biophysicist, James Till. Iscove highlights not only how the pair were renowned for their scientific rigor, but also for their
balanced, interdisciplinary partnership. Indeed, the valueof forming alliances acrossexperimental specialties is also a featured
topic in the Perspective article from Vunjak-Novakovic and Scadden. They describe how the field of tissue bioengineering has
grownand is poised for rapid development based in large part to an improved degree of interaction between cell biologists and
tissue engineers. The construction of biomimetic niches represents apoint of intersectionbetween these
two communities that offers the potential for designing basic inquirymodels to learn about development
and differentiation and also for the construction of therapeutically relevant replacement organs or organ
support systems.McCullochmayno longer bewith us, but his legacy is secure, andweall look forward to
watching where his example will lead the field he helped to found.
Inching Closer to Therapies
Challenges facing the regenerativemedicine community include the identification of candidate stemcell
populations to target, or transfer, the ability to prevent immune rejection of transplanted populations
and learning to overcome the endogenous pathology that led to the original damage that necessitated
replacement cells or organs. Three independent articles in this issue tackle these ongoing concerns.
Smukler and colleagues extend their earlier identification of pancreas-derived multipotent progenitors (PMPs) and show
that this population expresses insulin and can be isolated from islets of bothmouse and human pancreas.While PMPs appear
to be rare, they do exhibit functional regenerative activity, as both mouse and human PMPs can ameliorate diabetes in trans-
planted mice. Wu and colleagues offer encouraging results to suggest that brief exposure to anticostimulatory molecules
provides sufficient immune suppression to achieve survival of human pluripotent stem cells and their derivatives in an animal
host. Importantly, this treatment regimen did not leave the treatedmice susceptible to subsequent immune challenge. Finally,
by deriving patient-specific iPSCs from a Parkinson’s Disease patient bearing a known susceptibility mutation, Reijo Pera and
colleagues reveal that human dopamine neurons derived from the LRRK2mutant pluripotent cells exhibit enhanced sensitivity
to a variety of stress signals. This system may serve as an informative drug discovery platform and may also offer insight into
candidate strategies designed to protect healthy neurons from disease progression.Cell Stem Cell 8, March 4, 2011 ª2011 Elsevier Inc. xi
